Your browser doesn't support javascript.
loading
Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival.
Chan, Stefanie; Sridhar, Praveen; Kirchner, Rory; Lock, Ying Jie; Herbert, Zach; Buonamici, Silvia; Smith, Peter; Lieberman, Judy; Petrocca, Fabio.
Afiliação
  • Chan S; Division of Computational Biomedicine, Department of Surgery, Boston University School of Medicine, Boston, Massachusetts.
  • Sridhar P; Division of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
  • Kirchner R; Division of Computational Biomedicine, Department of Surgery, Boston University School of Medicine, Boston, Massachusetts.
  • Lock YJ; Division of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
  • Herbert Z; Bioinformatics Core, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Buonamici S; Division of Computational Biomedicine, Department of Surgery, Boston University School of Medicine, Boston, Massachusetts.
  • Smith P; Division of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
  • Lieberman J; Molecular Biology Core Facilities, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Petrocca F; H3 Biomedicine Inc., Cambridge, Massachusetts.
Mol Cancer Ther ; 16(12): 2849-2861, 2017 Dec.
Article em En | MEDLINE | ID: mdl-28878028
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Splicing de RNA / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Splicing de RNA / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2017 Tipo de documento: Article